Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Oxford Ledge is still expanding full research coverage of RVPH. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Reviva Pharmaceuticals develops next-generation therapeutics for neuropsychiatric and other diseases, with two proprietary drug candidates in clinical development.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-05-13
- 8-K Results of operations / financial condition; Regulation FD disclosure; Financial statements and exhibits 2026-05-13
- 8-K Delisting / transfer of listing; Other material event 2026-05-13
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-04-15
- 8-K Results of operations / financial condition; Regulation FD disclosure; Financial statements and exhibits 2026-03-30
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for RVPH. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open RVPH in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.